New mid-stage data from Biogen’s Ionis-partnered therapy diranersen served to both validate the tau hypothesis in Alzheimer’s ...

Novo Nordisk plans to launch the oral pill in more countries in the second half of 2026. Rival Eli Lilly's oral weight loss ...

Whether prepping for red carpets or maintaining skin between appointments, the latest high-tech beauty devices and ...

Avere Therapeutics’ lead program, AVR-001, is a differentiated oral peptide interleukin-23 (IL-23) receptor antagonist, with Phase 1b psoriasis data supporting its potential to be rapidly developed as ...

Celcuity wins FDA approval for REVTORPYK in HR+/HER2- breast cancer; outlook tempered by phase 3 data, competition & launch ...

Already an established treatment for drug-resistant epilepsy, the ketogenic diet is now drawing interest as a potential adjunctive therapy for TRD, schizophrenia, and bipolar disorder.

Desert Recovery Centers is highlighting the role of privacy, individualized clinical planning, and continuing care in women’s residential treatment at its Scottsdale location. The announcement focuses ...

Long Beach Blues Society founder Bill Grisolia believes the music itself is the lifeline. “Exposure is key; once you hear it ...

A bill supported by L.A. County Dist. Atty. Nathan Hochman seeks to help place abused animals with a foster home or rescue ...

NovoCure Limited downgrade after TRIDENT OS miss; growth catalysts, raised 2026 guidance, and key risks ahead. Click for this ...

McConnell said he intends to finish his term, which expires in January.

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has granted ...